Skip to main content
Journal cover image

Phase 3 Study of Androgen Deprivation Therapy (ADT) with Enzalutamide (ENZA) or Placebo (PBO) in Metastatic Hormone-Sensitive Prostate Cancer (MHSPC): The Arches Trial

Publication ,  Conference
Horvath, L; Armstrong, AJ; Szmulewitz, R; Petrylak, D; Villers, A; Azad, A; Alcaraz, A; Alekseev, B; Iguchi, T; Shore, ND; Rosbrook, B ...
Published in: ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
July 1, 2019

Duke Scholars

Published In

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

EISSN

1743-7563

ISSN

1743-7555

Publication Date

July 1, 2019

Volume

15

Start / End Page

32 / 33

Publisher

WILEY

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Horvath, L., Armstrong, A. J., Szmulewitz, R., Petrylak, D., Villers, A., Azad, A., … Stenzl, A. (2019). Phase 3 Study of Androgen Deprivation Therapy (ADT) with Enzalutamide (ENZA) or Placebo (PBO) in Metastatic Hormone-Sensitive Prostate Cancer (MHSPC): The Arches Trial. In ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (Vol. 15, pp. 32–33). WILEY.
Horvath, Lisa, Andrew J. Armstrong, Russell Szmulewitz, Daniel Petrylak, Arnauld Villers, Arun Azad, Antonio Alcaraz, et al. “Phase 3 Study of Androgen Deprivation Therapy (ADT) with Enzalutamide (ENZA) or Placebo (PBO) in Metastatic Hormone-Sensitive Prostate Cancer (MHSPC): The Arches Trial.” In ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 15:32–33. WILEY, 2019.
Horvath L, Armstrong AJ, Szmulewitz R, Petrylak D, Villers A, Azad A, et al. Phase 3 Study of Androgen Deprivation Therapy (ADT) with Enzalutamide (ENZA) or Placebo (PBO) in Metastatic Hormone-Sensitive Prostate Cancer (MHSPC): The Arches Trial. In: ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. WILEY; 2019. p. 32–3.
Horvath L, Armstrong AJ, Szmulewitz R, Petrylak D, Villers A, Azad A, Alcaraz A, Alekseev B, Iguchi T, Shore ND, Rosbrook B, Sugg J, Baron B, Chen L, Stenzl A. Phase 3 Study of Androgen Deprivation Therapy (ADT) with Enzalutamide (ENZA) or Placebo (PBO) in Metastatic Hormone-Sensitive Prostate Cancer (MHSPC): The Arches Trial. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. WILEY; 2019. p. 32–33.
Journal cover image

Published In

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

EISSN

1743-7563

ISSN

1743-7555

Publication Date

July 1, 2019

Volume

15

Start / End Page

32 / 33

Publisher

WILEY

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis